What About Johnson&Johnson

The vaccine had high efficacy at preventing hospitalization and death in people who did get sick. I have read that after receiving the J&J/Janssen COVID-19 Vaccine, there is a risk for a rare but serious adverse event, blood clots with low platelets. Women younger than 50 years old should especially be aware of their increased risk for this rare adverse event.
 

Forum List

Back
Top